Market Access Views & Analysis

Views & Analysis

Biden administration – What can the healthcare industry expe...

As Joe Biden takes the reins at the White House, pharmaphorum asks experts how his presidential tenure may influence the global healthcare industry.

Views & Analysis

2021 - UK market access prospects

With a new year comes the opportunity to think ahead for the market access landscape for the coming year.

Market Access

Why cell therapy manufacture is a team sport

Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that sits behind the process of individualised cell therapy – and why team cult

Views & Analysis

Nine for 2021: The COVID-19 legacy

In the first of a two part series, IQVIA's Sarah Rickwood covers nine key trends and events that will affect the global healthcare and pharmaceutical industries in 2021.

Views & Analysis

ABPI chief exec on the UK industry’s learnings from COVID-19

The ABPI’s chief executive Dr Richard Torbett shares his views on how the industry has adapted to COVID-19 and explains why the post-pandemic future is looking bright for the UK industry.

Views & Analysis

The critical role of the generics sector during the pandemic

Graeme Duncan from ADVANZ PHARMA explores how successful cross-industry collaboration between pharma and generics companies has helped support supply challenges during the pandemic.

Biden administration – What can the healthcare industry expe...

2021 - UK market access prospects

Why cell therapy manufacture is a team sport

Nine for 2021: The COVID-19 legacy

ABPI chief exec on the UK industry’s learnings from COVID-19

The critical role of the generics sector during the pandemic

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Views & Analysis

Editor's Picks